Ovarian Cancer Clinical Trial
Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
Summary
The purpose of this study is to determine the feasibility of routine referral to genetic counseling for all patients with a new diagnosis of epithelial ovarian, primary peritoneal or fallopian tube cancer.
Eligibility Criteria
Inclusion Criteria:
All subjects must have a new diagnosis of epithelial ovarian, primary peritoneal, fallopian tube or extra- uterine mullerian cancer.
All subjects must have either undergone primary surgery or be planning neoadjuvant chemotherapy for the treatment of ovarian, primary peritoneal or fallopian tube cancer.
All subjects must be able to comprehend and communicate in English.
All subjects must agree to participate.
A previous diagnosis of cancer is not an exclusion criterion.
Previous genetic screening is not an exclusion criterion.
Exclusion Criteria:
Patients who do not meet the above inclusion criteria.
Patients with a diagnosis of a low malignant potential mullerian tumor.
Patients who are not proficient in English language because the survey aspect of this study is comprised of 4 validated surveys that are only available in English language.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10016, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.